Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-09-01
|
| Series: | Clinical and Translational Medicine |
| Online Access: | https://doi.org/10.1002/ctm2.895 |
| _version_ | 1811242840435458048 |
|---|---|
| author | Hildur Arnardottir Sven‐Christian Pawelzik Philip Sarajlic Alessandro Quaranta Johan Kolmert Dorota Religa Craig E. Wheelock Magnus Bäck |
| author_facet | Hildur Arnardottir Sven‐Christian Pawelzik Philip Sarajlic Alessandro Quaranta Johan Kolmert Dorota Religa Craig E. Wheelock Magnus Bäck |
| author_sort | Hildur Arnardottir |
| collection | DOAJ |
| first_indexed | 2024-04-12T13:57:07Z |
| format | Article |
| id | doaj.art-7b01df0952c74a758a457980f061c8e5 |
| institution | Directory Open Access Journal |
| issn | 2001-1326 |
| language | English |
| last_indexed | 2024-04-12T13:57:07Z |
| publishDate | 2022-09-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical and Translational Medicine |
| spelling | doaj.art-7b01df0952c74a758a457980f061c8e52022-12-22T03:30:20ZengWileyClinical and Translational Medicine2001-13262022-09-01129n/an/a10.1002/ctm2.895Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trialHildur Arnardottir0Sven‐Christian Pawelzik1Philip Sarajlic2Alessandro Quaranta3Johan Kolmert4Dorota Religa5Craig E. Wheelock6Magnus Bäck7Department of Medicine Solna Karolinska Institutet Theme Heart, Vessels, and Neuro Karolinska University Hospital Stockholm SwedenDepartment of Medicine Solna Karolinska Institutet Theme Heart, Vessels, and Neuro Karolinska University Hospital Stockholm SwedenDepartment of Medicine Solna Karolinska Institutet Theme Heart, Vessels, and Neuro Karolinska University Hospital Stockholm SwedenDivision of Physiological Chemistry 2 Department of Medical Biochemistry and Biophysics Karolinska Institute Stockholm SwedenDivision of Physiological Chemistry 2 Department of Medical Biochemistry and Biophysics Karolinska Institute Stockholm SwedenDepartment of Neurobiology Karolinska Institutet and Theme Ageing Karolinska University Hospital Stockholm SwedenDivision of Physiological Chemistry 2 Department of Medical Biochemistry and Biophysics Karolinska Institute Stockholm SwedenDepartment of Medicine Solna Karolinska Institutet Theme Heart, Vessels, and Neuro Karolinska University Hospital Stockholm Swedenhttps://doi.org/10.1002/ctm2.895 |
| spellingShingle | Hildur Arnardottir Sven‐Christian Pawelzik Philip Sarajlic Alessandro Quaranta Johan Kolmert Dorota Religa Craig E. Wheelock Magnus Bäck Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial Clinical and Translational Medicine |
| title | Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial |
| title_full | Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial |
| title_fullStr | Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial |
| title_full_unstemmed | Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial |
| title_short | Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial |
| title_sort | immunomodulation by intravenous omega 3 fatty acid treatment in older subjects hospitalized for covid 19 a single blind randomized controlled trial |
| url | https://doi.org/10.1002/ctm2.895 |
| work_keys_str_mv | AT hildurarnardottir immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT svenchristianpawelzik immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT philipsarajlic immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT alessandroquaranta immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT johankolmert immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT dorotareliga immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT craigewheelock immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT magnusback immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial |